The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation

Molecular Endocrinology

Volumn 25, Issue 7, 2011, Pages 1137-1144

  Liu, Rong ^a   Zhou, Zhongmei ^a,b   Zhao, Dong ^a   Chen, Ceshi ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYTOKERATIN 5; ESTROGEN; KRUPPEL LIKE FACTOR 5; MESSENGER RNA; PROGESTERONE; REPLICATION LICENSING FACTOR CDT1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F3;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL DEDIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-5; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MAMMARY GLANDS, ANIMAL; MICE; NEOPLASMS, HORMONE-DEPENDENT; PREGNANCY; PROGESTERONE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANSCRIPTION, GENETIC;

CYCLINA;

EID: 79959832245     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0497     Document Type: Article

References (44)

1. Conneely OM, Mulac-Jericevic B, Arnett-Mansfield R 2007 Progesterone signaling in mammary gland development. Ernst Schering Found Symp Proc, pp 45-54
2. Ismail PM, Amato P, Soyal SM, DeMayo FJ, Conneely OM, O'Malley BW, Lydon JP 2003 Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 68:779-787
3. Lange CA 2008 Challenges to defining a role for progesterone in breast cancer. Steroids 73:914-921
4. Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, Bottino MC, Giulianelli S, Cerliani JP, Wargon V, Molinolo A 2009 The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer 16:333-350
5. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R 2000 Estrogen-progestin replacement and risk of breast cancer. JAMA 284:691-694
6. Kirsh V, Kreiger N 2002 Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada. Cancer Causes Control 13:583-590
7. Beral V 2003 Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
8. Hissom JR, Moore MR 1987 Progestin effects on growth in the human breast cancer cell line T-47D-possible therapeutic implications. Biochem Biophys Res Commun 145:706-711
9. Liang Y, Besch-Williford C, Brekken RA, Hyder SM 2007 Progestin- dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics. Cancer Res 67: 9929-9936
10. Jabara AG 1967 Effects of progesterone on 9,10-dimethyl-1,2- benzanthracene-induced mammary tumours in Sprague-Dawley rats. Br J Cancer 21:418-429
11. Benakanakere I, Besch-Williford C, Schnell J, Brandt S, Ellersieck MR, Molinolo A, Hyder SM 2006 Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats. Clin Cancer Res 12:4062-4071
12. Blank EW, Wong PY, Lakshmanaswamy R, Guzman R, Nandi S 2008 Both ovarian hormones estrogen and progesterone are neces-sary for hormonal mammary carcinogenesis in ovariectomized ACI rats. Proc Natl Acad Sci USA 105:3527-3532
13. Concannon PW, Spraker TR, Casey HW, Hansel W 1981 Gross and histopathologic effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult beagle bitches. Fertil Steril 36:373-387
14. Sartorius CA, Harvell DM, Shen T, Horwitz KB 2005 Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. Cancer Res 65: 9779-9788
15. Horwitz KB, Dye WW, Harrell JC, Kabos P, Sartorius CA 2008 Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. Proc Natl Acad Sci USA 105:5774-5779
16. Kabos P, Haughian JM, Wang X, Dye WW, Finlayson C, Elias A, Horwitz KB, Sartorius CA 28 July 2010 Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers. Breast Cancer Res Treat 10.1007/ s10549-010-1078-6
17. Haslam S Role of progesterone in the etiology of breast cancer in an animal model. BIT's 3rd World Cancer Congress: Breast Cancer Conference, Shanghai, China, 2010, p. 146.
18. Chen C, Benjamin MS, Sun X, Otto KB, Guo P, Dong XY, Bao Y, Zhou Z, Cheng X, Simons JW, Dong JT 2006 KLF5 promotes cell proliferation and tumorigenesis through gene regulationin the TSUPr1 human bladder cancer cell line. Int J Cancer 118:1346-1355
19. Zheng HQ, Zhou Z, Huang J, Chaudhury L, Dong JT, Chen C 2009 Kruppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Oncogene 28:3702-3713
20. Liu R, Zheng HQ, Zhou Z, Dong JT, Chen C 2009 KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. J Biol Chem 284:16791-16798
21. Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, Fujiu K, Nishimura G, Maemura K, Yamauchi T, Kubota N, Suzuki R, Kitamura T, Akira S, Kadowaki T, Nagai R 2005 Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab 1:27-39
22. Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, Nishimura G, Shindo T, Maemura K, Kagechika H, Shudo K, Nagai R 2005 Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res 97:1132-1141
23. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, Lim CA, Robson P, Zhong S, Ng HH 2008 A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10:353-360
24. Parisi S, Passaro F, Aloia L, Manabe I, Nagai R, Pastore L, Russo T 2008 Klf5 is involved in self-renewal of mouse embryonic stem cells. J Cell Sci 121:2629-2634
25. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA 2008 An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40:499-507
26. Tong D, Czerwenka K, Heinze G, Ryffel M, Schuster E, Witt A, Leodolter S, Zeillinger R 2006 Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin Cancer Res 12:2442-2448
27. Chen C, Zhou Y, Zhou Z, Sun X, Otto KB, Uht RM, Dong JT 2004 Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. Gene 330:133-142
28. Yin P, Lin Z, Cheng YH, Marsh EE, Utsunomiya H, Ishikawa H, Xue Q, Reierstad S, Innes J, Thung S, Kim JJ, Xu E, Bulun SE 2007 Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. J Clin Endocrinol Metab 92:4459-4466
29. Graham JD, Mote PA, Salagame U, van Dijk JH, Balleine RL, Huschtscha LI, Reddel RR, Clarke CL 2009 DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 150:3318-3326
30. Boonyaratanakornkit V, McGowan E, Sherman L, Mancini MA, Cheskis BJ, Edwards DP 2007 The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol 21:359-375
31. Zhao D, Zheng HQ, Zhou Z, Chen C 2010 The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Cancer Res 70:4728-4738
32. Said TK, Conneely OM, Medina D, O'Malley BW, Lydon JP 1997 Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. Endocrinology 138: 3933-3939
33. Bateman NW, Tan D, Pestell RG, Black JD, Black AR 2004 Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem 279:12093-12101
34. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA 1998 A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA 95:5076-5081
35. Guo P, Dong XY, Zhao KW, Sun X, Li Q, Dong JT 2010 Estrogeninduced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells. Int J Cancer 126:81-89
36. Sun R, Chen X, Yang VW 2001 Intestinal-enriched Kruppel-like factor (Kruppel-like factor 5) is a positive regulator of cellular proliferation. J Biol Chem 276:6897-6900
37. Beckers J, Herrmann F, Rieger S, Drobyshev AL, Horsch M, Hrabé de Angelis M, Seliger B 2005 Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis. Int J Cancer 114:590-597
38. Ziemer LT, Pennica D, Levine AJ 2001 Identification of a mouse homolog of the human BTEB2 transcription factor as a β-cateninindependent Wnt-1-responsive gene. Mol Cell Biol 21:562-574
39. Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, Joseph JD, Toner AP, Brown M, McDonnell DP 2009 Induction of Kruppel- like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Mol Endocrinol 23:1385-1396
40. Lee MY, Moon JS, Park SW, Koh YK, Ahn YH, Kim KS 2009 KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells. Biochem J 417:313-322
41. Aupperlee MD, Smith KT, Kariagina A, Haslam SZ 2005 Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development. Endocrinology 146:3577-3588
42. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery Jr CA, Shyamala G, Conneely OM, O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9:2266-2278
43. Wan H, Luo F, Wert SE, Zhang L, Xu Y, Ikegami M, Maeda Y, Bell SM, Whitsett JA 2008 Kruppel-like factor 5 is required for perinatal lung morphogenesis and function. Development 135:2563-2572
44. Chen C, Sun X, Ran Q, Wilkinson KD, Murphy TJ, Simons JW, Dong JT 2005 Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene 24:3319-3327